| Literature DB >> 24895543 |
Xiaohong Li1, Hai-Wei Yang2, Hao Chen3, Jing Wu1, Yehai Liu1, Ji-Fu Wei3.
Abstract
The house dust mites are major sources of indoor allergens for humans, which induce asthma, rhinitis, dermatitis, and other allergic diseases. Der f 25 is a triosephosphate isomerase, representing the major allergen identified in Dermatophagoides farinae. The objective of this study was to predict the B and T cell epitopes of Der f 25. In the present study, we analyzed the physiochemical properties, function motifs and domains, and structural-based detailed features of Der f 25 and predicted the B cell linear epitopes of Der f 25 by DNAStar protean system, BPAP, and BepiPred 1.0 server and the T cell epitopes by NetMHCIIpan-3.0 and NetMHCII-2.2. As a result, the sequence and structure analysis identified that Der f 25 belongs to the triosephosphate isomerase family and exhibited a triosephosphate isomerase pattern (PS001371). Eight B cell epitopes (11-18, 30-35, 71-77, 99-107, 132-138, 173-187, 193-197, and 211-224) and five T cell epitopes including 26-34, 38-54, 66-74, 142-151, and 239-247 were predicted in this study. These results can be used to benefit allergen immunotherapies and reduce the frequency of mite allergic reactions.Entities:
Year: 2014 PMID: 24895543 PMCID: PMC4033504 DOI: 10.1155/2014/483905
Source DB: PubMed Journal: Int J Genomics ISSN: 2314-436X Impact factor: 2.326
Figure 1Phylogenetic relationship of Der f 25 amino acid sequence with other homologs.
Figure 2Sequences and second structure analysis of Der f 25 allergen. Ten α-helices and seven β-sheets were identified in Der f 25.
Figure 3Structural analysis of Der f 25. (a) Protein structure of Der f 25 homology model. (b) Superimposition between Der f 25 and 2I9E template. Der f 25 is depicted in red and 2I9E template is depicted in cyan. (c) Distribution of characteristic pattern in Der f 25. (d) Electrostatic potential representation on the Der f 25 protein surface.
Parameters used for proteins structural assessment.
| Protein | Structural assessment methods | Ramachandran plot (%) |
| MCBL (%) | CBA (%) |
|
| RMSD |
|---|---|---|---|---|---|---|---|---|
| Der f 25 | PROCHECK analysis | 93.0E | 0.10I | 100.0 | 99.0 | |||
| 7.0F | 0.42J | |||||||
| 0.0G | 0.23K | |||||||
| 0.0H | ||||||||
| ProSa | −10.1 | |||||||
| QMEAN | 0.772 | |||||||
| RMSD | 0L | |||||||
|
| ||||||||
| 2I9E | PROCHECK analysis | 93.4%E | 0.25I | 100.0 | 98.9 | |||
| 6.6%F | 0.55J | |||||||
| 0.0G | 0.37K | |||||||
| 0.0H | ||||||||
| ProSa | −10.24 | |||||||
| QMEAN | 0.798 | |||||||
| RMSD | 0.056L | |||||||
MCBL: distribution of the main chain bond lengths; CBA: distribution of the covalent bond angles.
EResidues in favorable regions; Fresidues in allowed regions; Gresidues in generally allowed regions; Hresidues in disallowed regions; I G-factor score of the dihedral bonds; J G-factor score of the covalent bonds; Koverall G-factor score; Lroot mean square deviation between Cα Der f 25 structure and 2I9E template.
Predicted B and T cell epitopes of Der f 25 allergen.
| Peptide | Type of epitope | Position | Sequence |
|---|---|---|---|
| P1 | B | 11–18 |
|
| P2 | B | 30–35 |
|
| P3 | B | 71–77 |
|
| P4 | B | 99–107 |
|
| P5 | B | 132–138 |
|
| P6 | B | 173–18 |
|
| P7 | B | 193–197 |
|
| P8 | B | 211–224 |
|
| P9 | T | 26–34 |
|
| P10 | T | 38–54 |
|
| P11 | T | 66–74 |
|
| P12 | T | 142–151 |
|
| P13 | T | 239–247 |
|
Charged residues are shown in a bold font; hydrophobic residues are depicted in italic.
Figure 4B cell and T cell epitopes superimposition on the surface of Der f 25 allergen structure.
The results of B and T cell epitopes predictions.
| Tools | Location of the prediction results | |
|---|---|---|
| B cell epitope prediction | DNAStar protean | 11–19, 28–35, 68–77, 95–111, 130–139, 173–187, 193–197, 211–225. |
| BPAP | 20–26, 32–52, 54–70, 86–93, 138–168, 175–209, 218–242. | |
| BepiPred | 11–18, 30–34, 71–78, 99–107, 132–138, 168–183, 194–199, 210–224. | |
|
| ||
| T cell epitope prediction (HLA-DR) | DRB1*01:01 | 5–13, 11–19, 10–18, 13–21, 24–32, 26–34, 39–47, 46–54, 50–58, 53–61, 57–65, 58–66, 60–68, 66–74, 73–81, 82–90, 89–97, 90–98, 104–112, 107–115, 114–122, 119–127, 122–130, 143–151, 142–150, 156–164, 157–165, 161–169, 163–171, 167–175, 187–195, 190–198, 191–199, 195–203, 197–205, 203–211, 205–213, 227–235, 228–236, 232–240, 235–243, 239–247. |
| DRB3*01:01 | 53–61, 66–74, 81–89, 191–199. | |
| DRB4*01:01 | 26–34, 38–46, 46–54, 48–56, 50–58, 107–115, 142–150, 158–166, 160–168, 238–246, 239–247. | |
| DRB5*01:01 | 5–13, 11–19, 13–21, 20–28, 24–32, 26–34, 39–47, 46–54, 59–67, 66–74, 73–81, 89–97, 90–98, 143–151, 146–154, 150–158, 163–171, 165–173, 166–174, 203–211, 228–236, 238–246, 239–247. | |
|
| ||
| T cell epitope prediction (HLA-DQ) | HLA-DQA10101-DQB10501 | 153–161, 154–162, 159–167, 160–168. |
| HLA-DQA10102-DQB10602 | 33–41, 40–48, 42–50, 57–65, 77–85, 117–125, 154–162, 192–200, 206–214, 213–221, 230–238, 237–245. | |
| HLA-DQA10501-DQB10201 | 19–27, 39–47, 37–45, 82–90, 100–108, 112–120, 122–130, 126–134, 158–166, 195–203, 220–228. | |
| HLA-DQA10501-DQB10301 | 6–14, 34–42, 38–46, 39–47, 58–66, 66–74, 69–77, 72–80, 74–82, 77–85, 82–90, 85–93, 107–115, 117–125, 121–129, 133–141, 161–169, 166–174, 167–175, 169–177, 172–180, 192–200, 195–203, 203–211, 205–213, 206–214, 207–215, 213–221, 215–233, 228–236, 230–238, 232–240, 237–245. | |